Vimarsana
Biggest News Aggregation in the World

Nanomab Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nanomab Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nanomab Technology Today - Breaking & Trending Today

NanoMab's Voting Power in Radiopharm Diluted - Vimarsana News

NanoMab's Voting Power in Radiopharm Diluted

Radiopharm Theranostics Limited (AU:RAD) has released an update. NanoMab Technology Limited has reported a change in its substantial holding in Rad...

Source: biztoc.com
Critical Analysis: Virax Biolabs Group (NASDAQ:VRAX) versus Lantheus (NASDAQ:LNTH) - Vimarsana News

Critical Analysis: Virax Biolabs Group (NASDAQ:VRAX) versus Lantheus (NASDAQ:LNTH)

Lantheus (NASDAQ:LNTH – Get Free Report) and Virax Biolabs Group (NASDAQ:VRAX – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership. Risk and Volatility Lantheus has a beta of […]

Dr Boreham's Crucible: Radiopharm Theronostics - Vimarsana News

Dr Boreham's Crucible: Radiopharm Theronostics

Cancer detection biotech Radiopharm Theronostics is planning to list on the Nasdaq, and not without good reason, Tim Boreham explains

Lantheus Holdings Rules The Medical Diagnostics Business World (NASDAQ:LNTH) - Vimarsana News

Lantheus Holdings Rules The Medical Diagnostics Business World (NASDAQ:LNTH)

Which of the healthcare producers of Diagnostic Solutions is now a better buy to help build your portfolio’s near-term capital value? Read more here.

Radiopharm Theranostics Ltd acquires IP for three cancer-fighting nanobodies targeting solid tumours - Vimarsana News

Radiopharm Theranostics Ltd acquires IP for three cancer-fighting nanobodies targeting solid tumours

Radiopharm Theranostics Ltd (ASX:RAD), which is busy growing its platform of radiopharmaceutical products, has added three cancer-combatting...